Amarin Corp. (AMRN) announced a $100 million non-equity financing after the bell Thursday with an investment fund managed by Pharmakon Advisors. Amarin is continuing its preparations to commercialize Vascepa capsules with the hiring of a sales force in the United States. The stock is now down 2.30 on 679K shares.
Amarin traded in a range for the majority of Thursday's session and closed down by 0.09 at $11.95. The stock finished near the middle of a 2-month range.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.